vs
Side-by-side financial comparison of Inspire Medical Systems, Inc. (INSP) and Orion Group Holdings Inc (ORN). Click either name above to swap in a different company.
Orion Group Holdings Inc is the larger business by last-quarter revenue ($216.3M vs $204.6M, roughly 1.1× Inspire Medical Systems, Inc.). On growth, Orion Group Holdings Inc posted the faster year-over-year revenue change (14.6% vs 1.6%). Over the past eight quarters, Orion Group Holdings Inc's revenue compounded faster (6.1% CAGR vs 2.2%).
Inspire Medical Systems, Inc. is a medical technology firm that develops, manufactures and commercializes implantable neurostimulation solutions for obstructive sleep apnea. Its core product serves patients intolerant to CPAP therapy, with main markets across North America, Europe, and select Asia-Pacific regions, operating in sleep medicine and otolaryngology segments.
Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.
INSP vs ORN — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $204.6M | $216.3M |
| Net Profit | — | $4.7M |
| Gross Margin | 86.5% | 12.0% |
| Operating Margin | 13.0% | — |
| Net Margin | — | 2.2% |
| Revenue YoY | 1.6% | 14.6% |
| Net Profit YoY | — | 435.7% |
| EPS (diluted) | $-0.39 | $0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $204.6M | $216.3M | ||
| Q4 25 | $269.1M | $233.2M | ||
| Q3 25 | $224.5M | $225.1M | ||
| Q2 25 | $217.1M | $205.3M | ||
| Q1 25 | $201.3M | $188.7M | ||
| Q4 24 | $239.7M | $216.9M | ||
| Q3 24 | $203.2M | $226.7M | ||
| Q2 24 | $195.9M | $192.2M |
| Q1 26 | — | $4.7M | ||
| Q4 25 | $136.1M | $-240.0K | ||
| Q3 25 | $9.9M | $3.3M | ||
| Q2 25 | $-3.6M | $841.0K | ||
| Q1 25 | $3.0M | $-1.4M | ||
| Q4 24 | $35.2M | $6.8M | ||
| Q3 24 | $18.5M | $4.3M | ||
| Q2 24 | $9.8M | $-6.6M |
| Q1 26 | 86.5% | 12.0% | ||
| Q4 25 | 86.6% | 11.6% | ||
| Q3 25 | 85.8% | 13.2% | ||
| Q2 25 | 84.0% | 12.6% | ||
| Q1 25 | 84.7% | 12.2% | ||
| Q4 24 | 85.0% | 14.0% | ||
| Q3 24 | 84.1% | 11.9% | ||
| Q2 24 | 84.8% | 9.5% |
| Q1 26 | 13.0% | — | ||
| Q4 25 | 17.1% | 2.2% | ||
| Q3 25 | 4.3% | 2.4% | ||
| Q2 25 | -1.5% | 1.7% | ||
| Q1 25 | -0.7% | 0.4% | ||
| Q4 24 | 13.3% | 4.4% | ||
| Q3 24 | 7.0% | 3.4% | ||
| Q2 24 | 2.6% | -1.4% |
| Q1 26 | — | 2.2% | ||
| Q4 25 | 50.6% | -0.1% | ||
| Q3 25 | 4.4% | 1.5% | ||
| Q2 25 | -1.7% | 0.4% | ||
| Q1 25 | 1.5% | -0.7% | ||
| Q4 24 | 14.7% | 3.1% | ||
| Q3 24 | 9.1% | 1.9% | ||
| Q2 24 | 5.0% | -3.4% |
| Q1 26 | $-0.39 | $0.12 | ||
| Q4 25 | $4.57 | $-0.00 | ||
| Q3 25 | $0.34 | $0.08 | ||
| Q2 25 | $-0.12 | $0.02 | ||
| Q1 25 | $0.10 | $-0.04 | ||
| Q4 24 | $1.17 | $0.22 | ||
| Q3 24 | $0.60 | $0.12 | ||
| Q2 24 | $0.32 | $-0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $98.9M | $6.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $792.3M | $166.7M |
| Total Assets | $911.4M | $478.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $98.9M | $6.3M | ||
| Q4 25 | $308.3M | $1.6M | ||
| Q3 25 | $322.6M | $4.9M | ||
| Q2 25 | $300.9M | $1.7M | ||
| Q1 25 | $369.2M | $13.0M | ||
| Q4 24 | $445.5M | $28.3M | ||
| Q3 24 | $411.0M | $28.3M | ||
| Q2 24 | $439.7M | $4.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $33.4M | ||
| Q1 25 | — | $23.3M | ||
| Q4 24 | — | $23.2M | ||
| Q3 24 | — | $28.0M | ||
| Q2 24 | — | $60.3M |
| Q1 26 | $792.3M | $166.7M | ||
| Q4 25 | $781.2M | $159.0M | ||
| Q3 25 | $666.5M | $157.9M | ||
| Q2 25 | $677.8M | $153.2M | ||
| Q1 25 | $635.7M | $150.8M | ||
| Q4 24 | $689.7M | $150.7M | ||
| Q3 24 | $696.6M | $142.4M | ||
| Q2 24 | $638.1M | $111.1M |
| Q1 26 | $911.4M | $478.7M | ||
| Q4 25 | $907.3M | $414.7M | ||
| Q3 25 | $807.7M | $422.4M | ||
| Q2 25 | $802.2M | $432.7M | ||
| Q1 25 | $730.8M | $416.3M | ||
| Q4 24 | $808.4M | $417.3M | ||
| Q3 24 | $796.2M | $430.3M | ||
| Q2 24 | $728.4M | $414.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | 0.15× | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
